Abstract
Stem cell transplant in India has been seeing a steady progressive growth over the last decade. Thirty abstracts related to various aspects of bone marrow transplant were presented in the annual conference of Indian Society of Hematology and Transfusion medicine in 2018. All abstracts which were published were reviewed. They were categorized into autologous transplants, allogeneic transplants, lab aspects and supportive care. They have been summarized to provide a snapshot of the data presented. These data are likely to encourage to start or enhance transplant activity at other centers.
Similar content being viewed by others
References
Naithani R (2018) Hematopoietic stem cell transplantation in India-2017 annual update. Indian J Hematol Blood Transfus 34(1):5–7
Modak K, Radhakrishnan V, Lama M, Kathrotiya M, Bhave JS, Kumar J et al (2018) Outcomes of consolidation with R-BEAM high dose chemoimmunotherapy and autologous hematopoietic cell rescue in high risk B-cell lymphoma: a tertiary care single center experience. Indian J Hematol Blood Transfus. November, S 385
Pai AA, Mani S, Panetta CJ, Ezhilpavai M, Stallon I, Balkrishnan B et al (2018) Pharmacokinetics of melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Indian J Hematol Blood Transfus. November, S 380
Kulkarni U, Devasia AJ, Korula A et al (2018) Clinical outcomes in multiple myeloma post-autologous transplantation—a single centre experience. Indian J Hematol Blood Transfus. https://doi.org/10.1007/s12288-018-0989-y
Malhotra P, Yanamandra U, Khadwal A et al (2018) Autologous stem cell transplantation for multiple myeloma: single centre experience from North India. Indian J Hematol Blood Transfus 34(2):261–267
Naithani R, Dayal N, Rai R, Pathak S, Singh M (2018) Autologous hematopoietic stem cell transplantation for multiple myeloma in India. Indian J Hematol Blood Transfus 34(3):564–565
Kapoor J, Soni P, Bhatia N, Agrawal N, Ahmed R, Mehta P et al (2018) Clinical profile and outcomes post allogenic hematopoietic stem cell transplantation in thalassemia patients: A single centre experience. Indian J Hematol Blood Transfus 50–51
Korula A, Devasia AJ, Fouzia NA et al (2018) Outcomes following allogeneic stem cell transplantation using non-sibling family donors. Indian J Hematol Blood Transfus. https://doi.org/10.1007/s12288-018-0988-z
Nikila R, Patel S, Sankaran M, Venkateswaran VS, Kesavan MR, Ramya U et al (2018) Balancing cure versus toxicity-haematopoietic stem cell transplantation for sickle cell anemia. Indian J Hematol Blood Transfus. November, S 200
Venkateswaran VS, Patel S, Sankaran M, Kesavan MR, Nikila R, Ramya U et al (2018) Treosulfan based conditioning regimen—reduced toxicity with excellent outcomes in children with primary immune deficiency. Indian J Hematol Blood Transfus. November, S 53
Uppuluri R, Sivasankaran M, Patel S, Swaminathan VV, Ravichandran N, Ramanan KM et al (2018) Haematopoietic stem cell transplantation for children with inherited bone marrow failure syndromes: a single centre experience over 15 years from India. Indian J Hematol Blood Transfus. November, S 204
Lahane CG, Apte S, Subramanian K, Phatale R, Roshan R (2018) Outcome of allogenic stem cell transplant in acute myeloid leukemia patients in a single centre over 7 yrs. Indian J Hematol Blood Transfus. November, S 378
Selvarajan S, Korula A, Fouzia NA, Abraham A, Srivastava A, Mathews V et al (2018) Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-centre experience. Indian J Hematol Blood Transfus. November, S 54
Venkateswaran VS, Meena S, Shivani P, Keasvan MR, Nikila, Ramya U et al (2018) Donor lymphocyte infusion in children—efficacy in preventing graft rejection and relapse— experience from a tertiary referral centre in southern India. Indian J Hematol Blood Transfus. November, S 10
Reba H, Korula A, Abraham A, Sindhuvi E, Lakshmi K, George B et al (2018) Impact of donor lymphocyte infusion in malignant and nonmalignant disease post-allogeneic stem cell transplant. Indian J Hematol Blood Transfus. November, S 383
Nagarajan R, Pai AA, Ravichandran AJ, Mani S, Mohanan E, Balakrishnan B et al (2018) GSTA1*B genotype influences intravenous busulfan pharmacokinetics and targeted dose adjustment in patients undergoing HSCT with busulfan based conditioning regimen. Indian J Hematol Blood Transfus. November, S 379
Balasubramanian P, Pai A, Ezhilpavai M, Nagarajan R, Eunice SE, Kavitha ML et al (2018) Targeted iv busulfan-based conditioning regimen in patients with acute myelogenous leukemia undergoing allogeneic hematopoietic stem cell transplantation—a single centre experience. Indian J Hematol Blood Transfus 34–35
Bharath Ram S, Bhat S, Nataraj KS, Badiger S, Kailasnath VP, Mallya P et al (2018) A prospective observational study of incidence of early cytomegalovirus reactivation and factors affecting it following allogeneic stem cell transplantation. Indian J Hematol Blood Transfus 205–206
Devasia AJ, Mammen S, Korula A, Abraham A, Fouzia NA et al (2018) A low incidence of cytomegalo virus infection following allogeneic hematopoietic stem cell transplantation despite a high seroprevalence. Indian J Hematol Blood Transfus 34(4):636–642
Suraj C, Korula A, Fouzia NA, Kavitha ML, Abraham A, Srivastava A, Mathews V et al (2018) Antifungal prophylaxis in acute GVHD post stem cell transplant—a single centre experience from Southern India. Indian J Hematol Blood Transfus. November, S 206
Upreti R, Sharma S, Satyanand K, Kapoor A, Asthana B, Venkatesan S et al (2018) Initial HSCT in non-HEPA filter AHU rooms: a single center experience. Indian J Hematol Blood Transfus. November, S 196
Kumar R, Kapoor R, Asthana B et al (2017) Single dose preemptive plerixafor for stem cell mobilization for ASCT after lenalidomide based therapy in multiple myeloma: impact in resource limited setting. Indian J Hematol Blood Transfus 33(4):463–469
Kumar K, Chezhian S, Prabhu D, Asokan L, Dharani B et al (2018) On demand plerixafor as a rescue strategy in healthy donors to achieve adequate stem cells—a pilot study. Indian J Hematol Blood Transfus. November, S 201
Prabha L, Kumar K, Chezhian S (2018) Psychiatric illness in bone marrow transplantation patients. Indian J Hematol Blood Transfus. November, S 203
Sathianathan P, George B (2018) Quality of life among allogenic hematopoietic stem cell transplant patients. Indian J Hematol Blood Transfus. November, S 386
Kesavan MR, Patel S, Sivasankaran M, Venkateswaran VS, Nikila R, Uppuluri R et al (2018) Normal growth and development post haematopoietic stem cell transplantation for thalassemia major using treosulfan based conditioning regimen—single centre long term study. Indian J Hematol Blood Transfus. November, S 49
Naithani R, Dayal N, Dixit G (2017) Single versus dual platform analysis for hematopoietic stem cell enumeration using ISHAGE protocol. Indian J Hematol Blood Transfus 33(3):370–374
Mishra S, Mammen JJ, George B, Nair S, Kulkarni U, Matthews N et al (2018) A study to compare Haematopoietic Progenitor Cell (HPC) determined on the Sysmex XN-9000 with flowcytometric CD34 count in peripheral blood and in the harvested peripheral blood stem cell graft from autologous and allogenic donors. Indian J Hematol Blood Transfus. November, S 9
Vani S, Devi AS, Chandramouleeswaran N, Meganathan V, Kumar NM, Yogesh NK et al (2018) Next generation sequencing: an accurate and unambiguous method for HLA whole genome typing. Indian J Hematol Blood Transfus. November, S 195
Srinivasan G, Eswari S, Sumithra S, Shaji RV, Edison ES (2018) Comparison of DNA based chimerism analysis with direct amplification using whole blood. Indian J Hematol Blood Transfus. November, S 202
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jeyaraman, P., Naithani, R. Highlights of Abstracts on Hematopoietic Stem Cell Transplant in Annual Conference of ISHBT 2018. Indian J Hematol Blood Transfus 35, 12–16 (2019). https://doi.org/10.1007/s12288-018-01067-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-018-01067-5